Replies to post #88778 on Anavex Life Sciences Corp (AVXL)

[imho]

The cost of phase2/3 for central nervous system drug cost on average $13,000 per patient.

Per month, correct? So I calculate $47 million/year for n=300. This may be on low end? I have seen as high as $25000 per patient when I googled it.

IMHO

[XenaLives]

But if it's shorter and cheaper and someone, say the Australian government or the Rett Society picks up the bulk of the tab what is the cost?

The cost of phase2/3 for central nervous system drug cost on average $13,000 per patient.